CardiologyEmergency Medicine
New-Onset Atrial Fibrillation
Assessment, rate control, rhythm control, and anticoagulation decisions for new-onset or paroxysmal atrial fibrillation.
Source: ESC 2020 AF Guidelines; NICE NG196
Used in: Atrial Fibrillation
Step 1 of ~9
question
Haemodynamic Stability?
Assess haemodynamic status immediately on ECG-confirmed AF.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Bivalirudin (PCI Anticoagulation) · Direct Thrombin Inhibitor / PCI
- Vernakalant · Atrial-selective antiarrhythmic
- Bivalirudin · Anticoagulation
- Atropine Eye Drops 1% / 0.01% · Antimuscarinic — Cycloplegic / Myopia Control
- Ripretinib (Specialist drug) · Switch-control KIT/PDGFRA tyrosine-kinase inhibitor
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109
Featured in these MRCEM clinical pathways
A deeper exam-focused version of this pathway is available on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only. Always apply local guidelines and clinical judgement.